Security key
15117F500
Cellectar Biosciences, Inc. - Common Stock (CLRB)
CUSIP: 15117F500
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 8,719,970
- Total 13F shares
- 12,486,174
- Share change
- -2,780,731
- Total reported value
- $14,874,276
- Price per share
- $1.19
- Number of holders
- 42
- Value change
- -$4,685,208
- Number of buys
- 25
- Number of sells
- 14
Report period
Q2 2021
Institutions
42
Top holders
10
CLRB full security history
Newer quarter: Q3 2021
Previous quarter: Q1 2021
Cellectar Biosciences, Inc. SEC filings
Cellectar Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15117F500
Recent filing periods:
Top shareholders of CLRB - Cellectar Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Consonance Capital Management LP |
13F
|
Company |
47%
|
4,074,074
|
$6,559,000 | — | 31 Mar 2021 | |
| Sio Capital Management, LLC |
13F
|
Company |
25%
|
2,188,058
|
$3,523,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
19%
|
1,643,404
|
$2,645,000 | — | 31 Mar 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
11%
|
920,000
|
$1,481,000 | — | 31 Mar 2021 | |
| Maven Securities LTD |
13F
|
Company |
10%
|
900,000
|
$1,447,000 | — | 31 Mar 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
10%
|
892,557
|
$1,437,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
8.1%
|
709,850
|
$1,143,000 | — | 31 Mar 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
7.6%
|
663,201
|
$1,068,000 | — | 31 Mar 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
7.4%
|
644,600
|
$1,038,000 | — | 31 Mar 2021 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
7%
|
606,358
|
$976,000 | — | 31 Mar 2021 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
4.5%
|
389,061
|
$626,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.8%
|
246,485
|
$397,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.8%
|
244,392
|
$393,000 | — | 31 Mar 2021 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
2.5%
|
220,321
|
$354,000 | — | 31 Mar 2021 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
1.8%
|
156,696
|
$252,000 | — | 31 Mar 2021 | |
| Squarepoint Ops LLC |
13F
|
Company |
1.6%
|
136,942
|
$220,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
95,438
|
$154,000 | — | 31 Mar 2021 | |
| Creative Planning |
13F
|
Company |
0.34%
|
30,000
|
$48,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.33%
|
28,609
|
$46,000 | — | 31 Mar 2021 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.26%
|
22,979
|
$37,000 | — | 31 Mar 2021 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.26%
|
22,945
|
$36,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.26%
|
22,909
|
$37,000 | — | 31 Mar 2021 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.25%
|
21,852
|
$35,000 | — | 31 Mar 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.24%
|
21,265
|
$34,000 | — | 31 Mar 2021 | |
| Sowell Financial Services LLC |
13F
|
Company |
0.2%
|
17,692
|
$24,000 | — | 31 Mar 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.18%
|
15,413
|
$25,000 | — | 31 Mar 2021 | |
| Prospera Financial Services Inc |
13F
|
Company |
0.17%
|
14,754
|
$24,000 | — | 31 Mar 2021 | |
| COZAD ASSET MANAGEMENT INC |
13F
|
Company |
0.13%
|
11,000
|
$18,000 | — | 31 Mar 2021 | |
| PVG ASSET MANAGEMENT CORP |
13F
|
Company |
0.12%
|
10,160
|
$16,357 | — | 31 Mar 2021 | |
| FIRST FOUNDATION ADVISORS |
13F
|
Company |
0.11%
|
10,000
|
$16,000 | — | 31 Mar 2021 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.11%
|
10,000
|
$16,000 | — | 31 Mar 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.11%
|
10,000
|
$16,000 | — | 31 Mar 2021 | |
| Tradewinds Capital Management, LLC |
13F
|
Company |
0.11%
|
10,000
|
$16,000 | — | 31 Mar 2021 | |
| Bank Julius Baer & Co. Ltd, Zurich |
13F
|
Company |
0.09%
|
7,500
|
$12,000 | — | 31 Mar 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.09%
|
7,414
|
$12,000 | — | 31 Mar 2021 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0.08%
|
6,900
|
$11,000 | — | 31 Mar 2021 | |
| Johnson Financial Group, Inc. |
13F
|
Company |
0.05%
|
4,500
|
$7,000 | — | 31 Mar 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.04%
|
3,311
|
$6,000 | — | 31 Mar 2021 | |
| US BANCORP \DE\ |
13F
|
Company |
0.03%
|
2,857
|
$5,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
2,219
|
$4,000 | — | 31 Mar 2021 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0.02%
|
2,000
|
$3,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
2,000
|
$3,000 | — | 31 Mar 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
364
|
$1,000 | — | 31 Mar 2021 |
Institutional Holders of Cellectar Biosciences, Inc. - Common Stock (CLRB) as of Q2 2021
As of 30 Jun 2021,
Cellectar Biosciences, Inc. - Common Stock (CLRB) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,486,174 shares.
The largest 10 holders included
Consonance Capital Management LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BOXER CAPITAL, LLC, BlackRock Inc., Maven Securities LTD, SABBY MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, and GSA CAPITAL PARTNERS LLP.
This page lists
42
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
42
Q2 2021 holders
42
Holder diff
0
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.